Advertisement
Canada markets closed

  • S&P/TSX

    21,885.38
    +11.66 (+0.05%)
     

  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     

  • DOW

    38,085.80
    -375.12 (-0.98%)
     

  • CAD/USD

    0.7327
    +0.0003 (+0.05%)
     

  • CRUDE OIL

    83.79
    +0.22 (+0.26%)
     

  • Bitcoin CAD

    88,170.88
    +491.10 (+0.56%)
     

  • CMC Crypto 200

    1,390.07
    +7.49 (+0.54%)
     

  • GOLD FUTURES

    2,344.80
    +2.30 (+0.10%)
     

  • RUSSELL 2000

    1,981.12
    -14.31 (-0.72%)
     

  • 10-Yr Bond

    4.7060
    +0.0540 (+1.16%)
     

  • NASDAQ futures

    17,771.75
    +204.25 (+1.16%)
     

  • VOLATILITY

    15.37
    -0.60 (-3.76%)
     

  • FTSE

    8,078.86
    +38.48 (+0.48%)
     

  • NIKKEI 225

    37,770.24
    +141.76 (+0.38%)
     

  • CAD/EUR

    0.6825
    +0.0004 (+0.06%)
     

Today's Research Reports on Titan Medical, Medicure, Aphria and Acerus Pharmaceuticals

ACCESSWIRE

NEW YORK, NY / ACCESSWIRE / August 31, 2018 / Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at http://rdinvesting.com and get exclusive access to our numerous research reports and market updates.

RDI Initiates Coverage on:

Titan Medical Inc.
https://rdinvesting.com/news/?ticker=TMD.TO

Medicure Inc.
https://rdinvesting.com/news/?ticker=MPH.V

Aphria Inc.
https://rdinvesting.com/news/?ticker=APH.TO

Acerus Pharmaceuticals Corporation
https://rdinvesting.com/news/?ticker=ASP.TO

Titan Medical's stock moved 1.17% higher Thursday, to close the day at $2.60. The stock recorded a trading volume of 17,450 shares, which was below its three months average volume of 47,735 shares. In the last year, Titan Medical's shares have traded in a range of 2.22 - 20.40. The share price has gained 17.12% from its 52 week low. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $3.66 is below its 200-day moving average of $7.08. Shares of Titan Medical have fallen approximately 77.19 percent year-to-date.

ADVERTISEMENT

Access RDI's Titan Medical Inc. Research Report at:
https://rdinvesting.com/news/?ticker=TMD.TO

On Thursday, shares of Medicure recorded a trading volume of 2,800 shares, which was below the three months average volume of 12,221 shares. The stock ended the day 4.48% lower at 6.82. The share price has gained 22.66% from its 52 week low with a 52 week trading range of 5.56 - 9.20. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $6.94 is greater than its 200-day moving average of $6.90. Shares of Medicure are trading at a Price to Earnings ratio of 2.46. Shares of Medicure have fallen approximately 8.46 percent year-to-date.

Access RDI's Medicure Inc. Research Report at:
https://rdinvesting.com/news/?ticker=MPH.V

Aphria's stock moved 1.78% lower Thursday, to close the day at $16.01. The stock recorded a trading volume of 17,793,498 shares, which was above its three months average volume of 5,143,295 shares. In the last year, Aphria's shares have traded in a range of 5.92 - 24.75. The share price has gained 170.44% from its 52 week low. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $11.21 is below its 200-day moving average of $11.95. Shares of the company are trading at a Price to Earnings ratio of 88.94. Shares of Aphria have fallen approximately 14.39 percent year-to-date.

Access RDI's Aphria Inc. Research Report at:
https://rdinvesting.com/news/?ticker=APH.TO

On Thursday, shares of Acerus Pharmaceuticals recorded a trading volume of 137,631 shares, which was below the three months average volume of 238,564 shares. The stock ended the day flat at 0.28. The share price has gained 180.00% from its 52 week low with a 52 week trading range of 0.10 - 0.52. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $0.25 is below its 200-day moving average of $0.29. Shares of Acerus Pharmaceuticals have fallen approximately 3.45 percent year-to-date.

Access RDI's Acerus Pharmaceuticals Corporation Research Report at:
https://rdinvesting.com/news/?ticker=ASP.TO

Our Actionable Research on Titan Medical Inc. (TSX:TMD.TO) and Medicure Inc. (TSXV:MPH.V) and Aphria Inc. (TSX:APH.TO) and Acerus Pharmaceuticals Corporation (TSX:ASP.TO) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com